This includes 7 out of 1757 enhancer/super enhancer nodes harboring breast cancer SNPs (Table S3), one of which is a super enhancer and targets the promoter of the MYC oncogene (Fig. 6b-c) that is constitutively expressed in many cancers, including breast and blood cancers21. The gene discussed is MYC; the disease is cancer.